A Phase Ib Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 01 May 2017
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Acronyms CAELYX
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 01 Feb 2016 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
- 31 Dec 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.